Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
University of Pisa
Pisa, ItaliaPublicaciones en colaboración con investigadores/as de University of Pisa (31)
2024
-
Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies
Annals of Surgical Oncology, Vol. 31, Núm. 1, pp. 97-114
-
Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments
European Journal of Surgical Oncology, Vol. 50, Núm. 1
-
Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study
European Journal of Surgical Oncology, Vol. 50, Núm. 6
-
Propensity Score-Matching Analysis Comparing Robotic Versus Laparoscopic Limited Liver Resections of the Posterosuperior Segments: An International Multicenter Study
Annals of surgery, Vol. 279, Núm. 2, pp. 297-305
-
Propensity score-matched analysis comparing robotic versus laparoscopic minor liver resections of the anterolateral segments: an international multi-center study of 10,517 cases
Annals of Surgery
2023
-
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
HEPATOLOGY COMMUNICATIONS, Vol. 7, Núm. 6
-
Impact of body mass index on perioperative outcomes of laparoscopic major hepatectomies
Surgery (United States), Vol. 174, Núm. 2, pp. 259-267
-
Impact of body mass index on the difficulty and outcomes of laparoscopic left lateral sectionectomy
European Journal of Surgical Oncology, Vol. 49, Núm. 8, pp. 1466-1473
-
Impact of liver cirrhosis and portal hypertension on minimally invasive limited liver resection for primary liver malignancies in the posterosuperior segments: An international multicenter study
European Journal of Surgical Oncology, Vol. 49, Núm. 10
-
Impact of liver cirrhosis, the severity of cirrhosis, and portal hypertension on the outcomes of minimally invasive left lateral sectionectomies for primary liver malignancies
Surgery (United States), Vol. 174, Núm. 3, pp. 581-592
-
Impact of neoadjuvant chemotherapy on the difficulty and outcomes of laparoscopic and robotic major liver resections for colorectal liver metastases: A propensity-score and coarsened exact-matched controlled study
European Journal of Surgical Oncology, Vol. 49, Núm. 7, pp. 1209-1216
-
Propensity-score Matched and Coarsened-exact Matched Analysis Comparing Robotic and Laparoscopic Major Hepatectomies: An International Multicenter Study of 4822 Cases
Annals of Surgery, Vol. 278, Núm. 6, pp. 969-975
2022
-
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Obesity Facts, Vol. 15, Núm. 3, pp. 321-335
-
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Clinical Nutrition, Vol. 41, Núm. 4, pp. 990-1000
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Insights into therapeutic products, preclinical research models, and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine
Cardiovascular research, Vol. 117, Núm. 6, pp. 1428-1433
-
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 9
2020
-
Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review
Clinical Nutrition, Vol. 39, Núm. 8, pp. 2368-2388
-
OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions
Obesity Facts, Vol. 13, Núm. 1, pp. 1-28
2019
-
P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1